Published in

Springer, International Journal of Clinical Oncology, 1(26), p. 111-117, 2020

DOI: 10.1007/s10147-020-01794-8

Links

Tools

Export citation

Search in Google Scholar

Combination of TAS-102 and bevacizumab as third-line treatment for metastatic colorectal cancer: TAS-CC3 study

This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO